107 related articles for article (PubMed ID: 3698051)
21. [Angioimmunoblastic lymphadenopathy. Remission obtained with prednimustine after failure of corticosteroid therapy and cyclophosphamide].
Donadio D; Navarro M; Izarn P; Clot J; Emberger JM
Nouv Presse Med; 1980 Jan; 9(3):188-9. PubMed ID: 7355106
[No Abstract] [Full Text] [Related]
22. Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents.
Pedersen-Bjergaard J; Hansen MM; Geisler CH; Nissen NI
Acta Med Scand; 1980; 207(3):215-20. PubMed ID: 6989170
[TBL] [Abstract][Full Text] [Related]
23. Prednimustine treatment in malignant lymphomas.
Szántó I; Fleischmann T; Eckhardt S
Oncology; 1989; 46(4):205-7. PubMed ID: 2662086
[TBL] [Abstract][Full Text] [Related]
24. Prednimustine.
Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-44. PubMed ID: 3952516
[No Abstract] [Full Text] [Related]
25. The antitumor effect of prednimustine in vitro and in vivo.
Hartley-Asp B
Semin Oncol; 1986 Mar; 13(1 Suppl 1):3-7. PubMed ID: 3952519
[TBL] [Abstract][Full Text] [Related]
26. Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
Boesen E; Mouridsen HT
Cancer Treat Rep; 1982 Dec; 66(12):2081-3. PubMed ID: 7139649
[TBL] [Abstract][Full Text] [Related]
27. [Acute monoblastic leukemia in non-Hodgkin's malignant lymphoma treated with prednimustine].
Mahe M; Raffi F; Grolleau JY; Baudot S
Therapie; 1989; 44(5):378-9. PubMed ID: 2814920
[No Abstract] [Full Text] [Related]
28. The pharmacokinetics of prednimustine and chlorambucil in the rat.
Newell DR; Shepherd CR; Harrap KR
Cancer Chemother Pharmacol; 1981; 6(1):85-91. PubMed ID: 7273268
[TBL] [Abstract][Full Text] [Related]
29. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
Ideström K; Kimby E; Björkholm M; Mellstedt H; Engstedt L; Gahrton G; Johansson B; Killander D; Robérts KH; Stalfelt AM; Udén AM; Wadman B; Wählby S
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1117-23. PubMed ID: 6897633
[TBL] [Abstract][Full Text] [Related]
30. Treatment of refractory chronic lymphocytic leukemia with prednimustine: a phase II study using strict response criteria.
Gandara DR; George CB; Ries CA; Koretz MM; Lewis JP
Cancer Chemother Pharmacol; 1987; 19(2):165-8. PubMed ID: 3568275
[TBL] [Abstract][Full Text] [Related]
31. [Prednimustine in treatment of acute leukemia in elderly patients].
Brandt L; Könyves I
Lakartidningen; 1977 Apr; 74(15):1490-3. PubMed ID: 321896
[No Abstract] [Full Text] [Related]
32. A randomized comparative study of prednimustine and doxorubicin in patients with metastatic breast cancer.
Allegra JC
Semin Oncol; 1986 Mar; 13(1 Suppl 1):42-4. PubMed ID: 3513319
[TBL] [Abstract][Full Text] [Related]
33. Estimation of chlorambucil, phenyl acetic mustard and prednimustine in human plasma by high-performance liquid chromatography.
Newell DR; Hart LI; Harrap KR
J Chromatogr; 1979 Sep; 164(1):114-9. PubMed ID: 541393
[No Abstract] [Full Text] [Related]
34. Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031).
Ehrsson H; Wallin I; Nilsson SO; Johansson B
Eur J Clin Pharmacol; 1983; 24(2):251-3. PubMed ID: 6840176
[TBL] [Abstract][Full Text] [Related]
35. Differentiated treatment of myeloma. A non-randomised phase two study.
Osby E; Reizenstein P
Anticancer Res; 1984; 4(3):163-4. PubMed ID: 6465855
[TBL] [Abstract][Full Text] [Related]
36. [Primary treatment results in myeloma disease using a cytostatic preparation].
Iavorkovskiĭ LI; Soloveĭ DIa; Udris OIu; Riauzova LIu; Bliumental' RIa
Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):36-40. PubMed ID: 7301789
[No Abstract] [Full Text] [Related]
37. Chlorozotocin: phase II evaluation in patients with myeloma.
Cornell CJ; Pajak TF; McIntyre OR
Cancer Treat Rep; 1984 Apr; 68(4):685-6. PubMed ID: 6231990
[No Abstract] [Full Text] [Related]
38. Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
Gockerman JP; Silberman H; Bartolucci AA
Cancer Treat Rep; 1987; 71(7-8):773-4. PubMed ID: 3300970
[No Abstract] [Full Text] [Related]
39. Studies on the pharmacokinetics of chlorambucil and prednimustine in man.
Newell DR; Calvert AH; Harrap KR; McElwain TJ
Br J Clin Pharmacol; 1983 Feb; 15(2):253-8. PubMed ID: 6849759
[TBL] [Abstract][Full Text] [Related]
40. Comparative carcinogenic activity of prednimustine, chlorambucil, prednisolone and chlorambucil plus prednisolone in Sprague-Dawley rats.
Berger MR; Habs M; Schmähl D
Arch Geschwulstforsch; 1985; 55(6):429-42. PubMed ID: 4083998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
